A Drug Is Credited With Slight Gains for Patients Who Have Lung Cancer

Wednesday, June 4, 2008 - 11:49 in Health & Medicine

The drug Erbitux lengthened the survival of patients with advanced lung cancer by about five weeks, researchers have reported.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net